New Cobe Cardioplegia System
510(k) K920312
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK920312 | Date1 Oct 1992 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- DTN
- Device Class
- Class II
- Regulation
- 21 CFR Part 870.4400
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 1 Oct 2026
The New Cobe Cardioplegia System is a Reservoir, Blood, Cardiopulmonary Bypass device designed for cardiopulmonary support during cardiac surgical procedures. It delivers cardioplegic solutions to arrest and protect the heart during open-heart surgery by maintaining myocardial perfusion and metabolic stability. The system integrates with extracorporeal circulation to ensure controlled delivery of cold or warm cardioplegia, reducing ischemic injury and improving postoperative recovery outcomes.
This device is intended for use in sterile surgical settings and is supplied as a reusable system, requiring proper cleaning, disinfection, and maintenance per manufacturer guidelines. It is classified as Class II under FDA regulations (21 CFR 870.4400) and holds a 510(k) clearance (K920312) for traditional pathways in cardiovascular applications. Compatibility with MRI environments is not specified, and its operation adheres to standard cardiopulmonary bypass protocols, with no single-use components noted in the regulatory data.
Other devices from Cobe Cardiovascular, Inc.
Questions
AI-generated answers, 1 Oct 2026
What is the Cobe Cardioplegia System used for?
The Cobe Cardioplegia System is designed for cardiopulmonary support during cardiac surgical procedures. It delivers cardioplegic solutions to arrest and protect the heart by maintaining myocardial perfusion and metabolic stability, thereby reducing ischemic injury and improving postoperative recovery outcomes.
Is the Cobe Cardioplegia System reusable or single-use?
The Cobe Cardioplegia System is a reusable device. It requires proper cleaning, disinfection, and maintenance as outlined by the manufacturer to ensure safe and effective use in sterile surgical settings.
What type of cardioplegia does this system support?
The system supports the delivery of both cold and warm cardioplegia, allowing clinicians to choose the appropriate temperature for their surgical procedure to optimize myocardial protection.
Are there any specific storage requirements for this device?
While the provided data does not specify detailed storage instructions, the Cobe Cardioplegia System is intended for use in sterile surgical environments. It should be stored and maintained according to the manufacturer’s guidelines to preserve its functionality and ensure sterility before use.
What regulatory pathway does this device follow?
The Cobe Cardioplegia System holds a 510(k) clearance (K920312) under the FDA’s traditional pathway and is classified as a Class II device under 21 CFR 870.4400. This classification applies to its use in cardiopulmonary bypass and cardioplegia delivery during cardiac surgery.